Plantimex Recalls Mamisan Lidocaine Ointment Containers Due To Risk Of Serious Injury Or Death From Child Poisoning; Violates Mandatory Standard For Child-resistant Packaging
Plantimex is recalling Mamisan Pain Relieving Topical Ointment because the container does not have child-resistant packaging as required by law. The ointment contains lidocaine, and if swallowed by young children, it could cause serious injury or death. The product was distributed nationwide.
- Recalling firm
- MiramarLab, of Doral, Florida
- Product
- Mamisan Pain Relieving Topical Ointment
- Reason
- The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- Classification
- Class I
- Category
- consumer product recall
- Country
- United States
- Agency
- U.S. Consumer Product Safety Commission
- Recall date
- 2025-12-18
- Status
- Ongoing
- Distribution
- Nationwide
Official recall notice from U.S. Consumer Product Safety Commission
Recall details on Nibble Recalls: https://trynibble.app/recalls/d17d8a80-0f51-44f9-9b78-36beeba170c7